Dr. Hideyo MIYAZAKI, Chief Representative of ARISE
(Director, Center Hospital, National Center for Global Health and Medicine)

 As of 1 July 2024, I assumed the position of Director at the Center Hospital of the National Center for Global Health and Medicine (NCGM), Chief Representative of ARISE, and at the same time was entrusted with the role of Chief Representative for ARISE. I am also leading the AMED Clinical Research and Clinical Trial Promotion Project, which focuses on building a clinical research and trial network for infectious diseases in Asia.
 The COVID-19 pandemic served as a reminder of the need for a unified global approach in research and development to respond promptly to the medical needs of the population. To achieve this goal, the National Center for Global Health and Medicine, in collaboration with major research institutions in Asia, launched the ARO Alliance for Southeast and East Asia (ARISE) in 2021.
ARISE aspires to be a leading network for clinical research and trials on infectious diseases, emphasizing the promotion of high-quality trials throughout Asia.
 In light with the forthcoming establishment of the Japan Institute of Health Security (JIHS) in April 2025, following the merger of the National Center for Global Health and Medicine with the National Institute for Infectious Diseases, ARISE will continue to prioritize its targeted projects.